ICU入住时MR-proADM升高预测脓毒症患者结局并与后续液体过负荷相关
该前瞻性队列研究纳入173例入住同一ICU的脓毒症患者,入院时及第5天采血检测PCT、MR-proADM、和肽素及CT-proET-1,评估各标志物对28天死亡风险的预测价值,并评价入院至第5天的液体平衡。ICU全因死亡率为36.4%。第1天除CT-proET-1外,所有标志物在非存活者中均显著高于存活者,尤以MR-proADM(8.6[5.9] vs 4.4[3.9] nmol/L;P<0.0001)和CT-proET-1/MR-proADM比值(52.9[22.4] vs 31.3[26.6]任意单位;P<0.0001)为著。第1天MR-proADM和CT-proET-1/MR-proADM比值的AUROCC最佳(分别为0.75[0.67-0.85]和0.82[0.75-0.89]),第5天准确度提高。MR-proADM基线水平与ICU入住后5天液体平衡强相关(Rho=0.41;P<0.001)。
要点
- 脓毒症患者ICU入住时MR-proADM是短期临床结局的最佳预测指标(第1天AUROCC 0.75[0.67-0.85]),优于其他标志物。
- 第1天非存活者MR-proADM为8.6[5.9] nmol/L,存活者为4.4[3.9] nmol/L(P<0.0001)。
- CT-proET-1/MR-proADM比值第1天AUROCC为0.82[0.75-0.89],预测准确度高于单一MR-proADM。
- MR-proADM基线水平与ICU入住后5天液体平衡强相关(Rho=0.41;P<0.001),可能预测液体潴留。
- 第5天标志物预测准确度较第1天提高。
适用人群与场景
- 入住同一ICU的脓毒症患者,共173例。
研究设计与关键结果
- 前瞻性队列研究,纳入173例入住同一ICU的脓毒症患者,入院时及第5天采血检测PCT、MR-proADM、和肽素及CT-proET-1,评估28天死亡风险及入院至第5天液体平衡。
- ICU全因死亡率为36.4%。
- 第1天除CT-proET-1外,所有标志物在非存活者中均显著高于存活者;MR-proADM为8.6[5.9] vs 4.4[3.9] nmol/L(P<0.0001),CT-proET-1/MR-proADM比值为52.9[22.4] vs 31.3[26.6]任意单位(P<0.0001)。
- 第1天MR-proADM的AUROCC为0.75[0.67-0.85],CT-proET-1/MR-proADM比值的AUROCC为0.82[0.75-0.89](95%CI)。
- 第5天预测准确度提高。
- MR-proADM基线水平与ICU入住后5天液体平衡强相关(Rho=0.41;P<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在入住ICU的脓毒症患者中,入院时MR-proADM与其他标志物相比是短期临床结局的最佳预测指标,这可能与其预测液体潴留的能力有关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Among septic patients admitted to the intensive care unit (ICU), early recognition of those with the highest risk of death is of paramount importance. We evaluated the prognostic value of Procalcitonin (PCT), mid regional-proadrenomedullin (MR-proADM), copeptine and CT-proendothelin 1 (CT-ProET 1) concentrations.
METHODS: This was a prospective cohort study, which included 173 septic patient admitted to one ICU. Blood samples for biomarker measurements were obtained upon admission and on day 5. The predictive value of each biomarker regarding the risk of death at day 28 was assessed. The fluid balance was evaluated from admission to day 5.
RESULTS: All cause ICU mortality was 36.4%. All the biomarkers except CT-ProET-1 were significantly more elevated in the non-survivors than in the survivors upon day 1. This was especially true for MR-proADM (8.6 [5.9] vs. 4.4 [3.9] nmol/L; P < 0.0001) and for the CT-proET-1/MR-proADM ratio (52.9 [22.4] vs. 31.3 [26.6] arbitrary units; P < 0.0001). The best AUROCC values on day 1 were obtained with MR-ProADM and the CT-proET-1/MR-proADM ratio as well (0.75 [0.67-0.85] and 0.82 [0.75-0.89]; 95% CI, respectively). An improved accuracy was achieved on day 5. Moreover, MR-ProADM baseline levels and fluid balance over the 5-day period following ICU admission were strongly correlated (Rho = 0.41; P < 0.001).
CONCLUSIONS: In patients admitted to the ICU with sepsis, MR-ProADM on admission was the best predictor of short-term clinical outcome if compared with others. This could be related to its ability to predict fluid sequestration.
参考来源
- Charles PE, Péju E, Dantec A, et al. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload. Shock. 2017. PMID: 28414691. doi:10.1097/SHK.0000000000000877
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。